Expanded carrier screening: A review of early implementation and literature

2005, Committee opinion no. 325: update on carrier screening for cystic fibrosis, Obstet Gynecol, 106, 1465, 10.1097/00006250-200512000-00055

Watson, 2004, Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel, Genet Med, 6, 387, 10.1097/01.GIM.0000139506.11694.7C

Prior, 2008, Professional practice and guidelines committee. Carrier screening for spinal muscular atrophy, Genet Med, 10, 840, 10.1097/GIM.0b013e318188d069

2001

Ross, 2012, A re-examination of the use of ethnicity in prenatal carrier testing, Am J Med Genet A, 158A, 19, 10.1002/ajmg.a.34361

Shafer, 1996, Newborn screening for sickle cell disease: 4 years of experience from California’s newborn screening program, J Pedatr Hematol Oncol, 18, 36, 10.1097/00043426-199602000-00007

U.S. Census Bureau. Statistical Abstract of the United States: 2011, 130th ed. Washington, DC; 2010.

Sheskin, 2010, 78

Bley, 2011, Natural history of infantile (GM2) gangliosidosis, Pediatrics, 128, e1233, 10.1542/peds.2011-0078

2007, Practice bulletin no. 78: hemoglobinopathies in pregnancy, Obstet Gynecol, 109, 229, 10.1097/00006250-200701000-00055

2009, Committee opinion no. 442: preconception and prenatal carrier screening for genetic diseases in individuals of Eastern European Jewish descent, Obstet Gynecol, 14, 950

Gross, 2008, Professional practice and guidelines committee. Carrier screening in individuals of Ashkenazi Jewish descent, Genet Med, 10, 54, 10.1097/GIM.0b013e31815f247c

Scott, 2010, Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseases, Hum Mutat, 31, 1240, 10.1002/humu.21327

Shao, 2015, Evaluation of a two-year Jewish genetic disease screening program in Atlanta: insight into community genetic screening approaches, J Community Genet, 6, 137, 10.1007/s12687-014-0208-y

Hoffman, 2014, The Ashkenazi Jewish carrier screening panel: evolution, status quo, and disparities, Prenat Diagn, 34, 1161, 10.1002/pd.4446

Kingsmore, 2012, Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases, PLoS Curr, 4, 10.1371/4f9877ab8ffa9

Srinivasan, 2010, A universal carrier test for the long tail of Mendelian disease, Reprod Biomed Online, 21, 537, 10.1016/j.rbmo.2010.05.012

Castellani, 2015, Cystic fibrosis carrier screening effects on birth prevalence and newborn screening, Genet Med

Hale, 2008, Newborn screening showing decreasing incidence of cystic fibrosis, N Engl J Med, 358, 973, 10.1056/NEJMc0707530

Haque, 2015, Expanded carrier screening of 322,484 individuals: the case for going beyond cystic fibrosis, Eur J Hum Genet, 23, S1

2003, ACOG practice bulletin. Neural tube defects. Clinical management guidelines for obstetricians–gynecologists. Number 44, July 2003, Int J Gynaecol Obstet, 83, 123, 10.1016/S0020-7292(03)00390-4

2007, ACOG practice bulletin no. 77: screening for fetal chromosomal abnormalities, Obstet Gynecol, 109, 217, 10.1097/00006250-200701000-00054

Wilcken, 2008, More on medium-chain acyl-Coenzyme A dehydrogenase deficiency in a neonate, N Engl J Med, 358, 647, 10.1056/NEJMc073220

Bailey, 2009, No change in the age of diagnosis for fragile X syndrome: findings from a national parent survey, Pediatrics, 124, 527, 10.1542/peds.2008-2992

Browning, 2006, Fetal fatty acid oxidation defects and maternal liver disease in pregnancy, Obstet Gynecol, 107, 115, 10.1097/01.AOG.0000191297.47183.bd

Grody, 2013, ACMG position statement on prenatal/preconception expanded carrier screening, Genet Med, 15, 482, 10.1038/gim.2013.47

Edwards, 2015, Expanded carrier screening in reproductive medicine—points to consider, Obstet Gynecol, 125, 653, 10.1097/AOG.0000000000000666

Elias, 1994, Generic consent for genetic screening, N Engl J Med, 330, 1611, 10.1056/NEJM199406023302213

Reeves, 2015, Comparison of informed consent preferences for multiplex genetic carrier screening among a diverse population, J Genet Counsel

Henneman, 2015, Responsible implementation of expanded carrier screening: Summary and recommendations of the European Society of Human Genetics, Eur J Hum Genet

Klugman, 2013, Detection of carriers in the Ashkenazi Jewish population: an objective comparison of high-throughput genotyping versus gene-by-gene testing, Genet Test Mol Biomarkers, 17, 763, 10.1089/gtmb.2013.0105

Bell, 2011, Carrier testing for severe childhood recessive diseases by next-generation sequencing, Sci Transl Med, 3, 65ra4, 10.1126/scitranslmed.3001756

Lazarin, 2013, An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals, Genet Med, 15, 178, 10.1038/gim.2012.114

Hallam, 2014, Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing, J Mol Diagn, 16, 180, 10.1016/j.jmoldx.2013.10.006

Lim, 2015, Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk, Genet Med

Lazarin, 2014, Systematic classification of disease severity for evaluation of expanded carrier screening panels, PLoS One, 9, e114391, 10.1371/journal.pone.0114391

Grody, 2007, The cystic fibrosis mutation “arms race”: when less is more, Genet Med, 9, 739, 10.1097/GIM.0b013e318159a331

Perrault-Micale, 2015, Rigorous approach for selection of optimal variant sets for carrier screening with demonstration of clinical utility, Mol Genet Genomics Med, 3, 363, 10.1002/mgg3.148

Ready, 2012, Knowledge and attitudes regarding expanded genetic carrier screening among women’s healthcare providers, Fert Ster, 97, 407, 10.1016/j.fertnstert.2011.11.007

Darcy, 2011, Cystic fibrosis carrier screening in obstetric clinical practice: knowledge, practices, and barriers, a decade after publication of screening guidelines, Genet Test Mol Biomarkers, 15, 517, 10.1089/gtmb.2010.0228

Lazarin, 2015, Genetic counselors’ perspectives and practices regarding expanded carrier screening after initial clinical availability, J Genet Couns

Benn, 2014, Obstetricians’ and gynecologists’ practice and opinions of expanded carrier testing and non-invasive prenatal testing, Prenat Diagn, 34, 145, 10.1002/pd.4272

Cho, 2013, Expanded carrier screening in reproductive healthcare: perspectives from genetics professionals, Hum Reprod, 28, 1725, 10.1093/humrep/det091

Holtkamp, 2015, Do people from the Jewish community prefer ancestry-based or pan-ethnic expanded carrier screening, Eur J Hum Genet